Compare LXFR & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LXFR | YDES |
|---|---|---|
| Founded | 1898 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Major Chemicals | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 459.5M | 543.0M |
| IPO Year | 2002 | 2024 |
| Metric | LXFR | YDES |
|---|---|---|
| Price | $17.23 | $5.79 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 390.0K | ★ 607.2K |
| Earning Date | 10-27-2026 | 08-31-2026 |
| Dividend Yield | ★ 3.02% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.31 | N/A |
| Revenue | ★ $384,600,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.26 | N/A |
| P/E Ratio | $55.63 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.26 | $1.70 |
| 52 Week High | $19.45 | $22.00 |
| Indicator | LXFR | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 52.14 | 56.50 |
| Support Level | $17.19 | $2.33 |
| Resistance Level | $17.38 | $9.11 |
| Average True Range (ATR) | 0.05 | 1.13 |
| MACD | -0.01 | 0.08 |
| Stochastic Oscillator | 31.32 | 59.60 |
Luxfer Holdings PLC is engaged in materials engineering and the manufacture of materials, components, and gas containment products. The company has two reportable segments: Elektron and Gas Cylinders. The Elektron segment produces specialty materials based on magnesium and zirconium for applications in aerospace, defense, automotive, and industrial markets. The Gas Cylinders segment manufactures high-pressure gas containment products using aluminum alloys and carbon composite technologies for use in healthcare, emergency response, aerospace, and alternative fuel transportation markets.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.